Position in LLY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$40,925,754
+$6,536,474 QoQ
Shares Held
34,121
-8.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
#604
of 4,605 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Atria Investments, Inc holds $241,408,936 across 16 Drug Manufacturers - General names. LLY ranks #2 (17.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
234,831 | $59,640,029 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
34,121 | $40,925,754 | |
| 3 | ABBV |
AbbVie Inc.
|
154,317 | $38,832,329 | |
| 4 | MRK |
Merck & Co., Inc.
|
190,293 | $24,452,650 | |
| 5 | AMGN |
Amgen Inc
|
43,724 | $15,833,334 | |
| 6 | AZN |
Astrazeneca PLC
|
69,989 | $13,271,314 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
76,216 | $9,629,129 | |
| 8 | NVS |
Novartis AG
|
60,245 | $9,441,596 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40,925,754 | 34,121 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $34,389,280 | 37,389 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $43,868,441 | 40,820 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $30,790,865 | 40,355 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $36,261,397 | 46,517 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $39,494,190 | 47,819 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $37,527,692 | 48,611 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $40,747,038 | 45,993 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $42,248,652 | 46,664 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $37,225,386 | 47,850 | Shares | Sole | 2024-05-21 | |
| 2023-12-31 | $24,599,224 | 42,200 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $20,856,757 | 38,830 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $18,070,268 | 38,531 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $14,427,761 | 42,012 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $16,248,783 | 44,415 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $14,116,814 | 43,658 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $13,917,896 | 42,926 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $10,810,753 | 37,751 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $9,284,306 | 33,612 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $8,023,442 | 34,726 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $7,764,202 | 33,828 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $5,553,037 | 29,724 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $7,097,864 | 42,039 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,705,874 | 38,548 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $10,631,968 | 64,758 | Shares | Sole | 2020-09-22 | |
| No filing history on record for this holder in this stock. | ||||||